2 hours Vertex Pharmaceuticals (NASDAQ:VRTX) Earns Sector Perform Rating from Analysts at ScotiabankMarketBeat
Scotiabank started coverage on shares of Vertex Pharmaceuticals in a research report on Wednesday. They issued a “sector perform” rating for the company.
Nasdaq 100 · Pharmaceuticals · Science · Scotiabank · Vertex (VRTX)
X